MedFirst Healthcare Services, Inc. (TPEX:4175)
Taiwan
· Delayed Price · Currency is TWD 63.50
-0.20 (-0.31%)
Apr 24, 2025, 1:30 PM CST
TPEX:4175 Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 7,734 | 7,446 | 7,224 | 6,540 | 5,927 | Upgrade
|
| Revenue Growth (YoY) | 3.87% | 3.08% | 10.46% | 10.34% | 11.73% | Upgrade
|
| Cost of Revenue | 5,351 | 5,177 | 5,018 | 4,614 | 4,103 | Upgrade
|
| Gross Profit | 2,383 | 2,269 | 2,206 | 1,927 | 1,825 | Upgrade
|
| Selling, General & Admin | 2,260 | 2,164 | 1,979 | 1,815 | 1,671 | Upgrade
|
| Operating Expenses | 2,260 | 2,164 | 1,978 | 1,814 | 1,673 | Upgrade
|
| Operating Income | 123.06 | 105.51 | 227.71 | 113.22 | 151.46 | Upgrade
|
| Interest Expense | -58.94 | -58.43 | -46.8 | -37.4 | -24.68 | Upgrade
|
| Interest & Investment Income | 5.83 | 8.47 | 3.12 | 1.79 | 2.3 | Upgrade
|
| Currency Exchange Gain (Loss) | 3.12 | -0.81 | 11.04 | -1.52 | -3.95 | Upgrade
|
| Other Non Operating Income (Expenses) | 22.6 | 20.83 | 24.1 | 13.95 | 14.04 | Upgrade
|
| EBT Excluding Unusual Items | 95.67 | 75.56 | 219.17 | 90.04 | 139.17 | Upgrade
|
| Impairment of Goodwill | - | -5.29 | -2.3 | -3.61 | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -0.01 | -0.29 | 0.29 | - | -0.87 | Upgrade
|
| Gain (Loss) on Sale of Assets | -0.51 | -0.27 | 0.87 | -22.85 | -0.38 | Upgrade
|
| Asset Writedown | -0.34 | -0.17 | - | -1.37 | - | Upgrade
|
| Legal Settlements | - | - | 0.85 | -7.57 | - | Upgrade
|
| Other Unusual Items | 0.57 | 0.34 | 3.08 | 0.88 | -7.29 | Upgrade
|
| Pretax Income | 95.39 | 69.89 | 221.96 | 58.96 | 130.62 | Upgrade
|
| Income Tax Expense | 25.4 | 22.36 | 46.28 | -7.33 | 26.17 | Upgrade
|
| Earnings From Continuing Operations | 69.99 | 47.53 | 175.68 | 66.29 | 104.46 | Upgrade
|
| Minority Interest in Earnings | -0.17 | -0.73 | -4.82 | 1.64 | 5.39 | Upgrade
|
| Net Income | 69.82 | 46.8 | 170.86 | 67.93 | 109.85 | Upgrade
|
| Net Income to Common | 69.82 | 46.8 | 170.86 | 67.93 | 109.85 | Upgrade
|
| Net Income Growth | 49.17% | -72.61% | 151.53% | -38.16% | -22.11% | Upgrade
|
| Shares Outstanding (Basic) | 42 | 42 | 39 | 38 | 37 | Upgrade
|
| Shares Outstanding (Diluted) | 42 | 42 | 42 | 42 | 41 | Upgrade
|
| Shares Change (YoY) | 0.07% | -0.18% | 0.32% | 3.20% | 7.86% | Upgrade
|
| EPS (Basic) | 1.65 | 1.13 | 4.41 | 1.80 | 2.96 | Upgrade
|
| EPS (Diluted) | 1.65 | 1.12 | 4.09 | 1.69 | 2.76 | Upgrade
|
| EPS Growth | 46.83% | -72.58% | 142.01% | -38.67% | -26.47% | Upgrade
|
| Free Cash Flow | 407.3 | 573.42 | 780 | 592.88 | 101.69 | Upgrade
|
| Free Cash Flow Per Share | 9.61 | 13.54 | 18.39 | 14.02 | 2.48 | Upgrade
|
| Dividend Per Share | 1.600 | 1.600 | 2.600 | 1.459 | 1.676 | Upgrade
|
| Dividend Growth | - | -38.45% | 78.13% | -12.94% | -45.00% | Upgrade
|
| Gross Margin | 30.81% | 30.47% | 30.53% | 29.46% | 30.78% | Upgrade
|
| Operating Margin | 1.59% | 1.42% | 3.15% | 1.73% | 2.56% | Upgrade
|
| Profit Margin | 0.90% | 0.63% | 2.37% | 1.04% | 1.85% | Upgrade
|
| Free Cash Flow Margin | 5.27% | 7.70% | 10.80% | 9.06% | 1.72% | Upgrade
|
| EBITDA | 304.9 | 287.19 | 396.14 | 266.93 | 267 | Upgrade
|
| EBITDA Margin | 3.94% | 3.86% | 5.48% | 4.08% | 4.50% | Upgrade
|
| D&A For EBITDA | 181.84 | 181.68 | 168.42 | 153.72 | 115.54 | Upgrade
|
| EBIT | 123.06 | 105.51 | 227.71 | 113.22 | 151.46 | Upgrade
|
| EBIT Margin | 1.59% | 1.42% | 3.15% | 1.73% | 2.56% | Upgrade
|
| Effective Tax Rate | 26.63% | 31.99% | 20.85% | - | 20.03% | Upgrade
|
Updated Nov 14, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.